Procaps Group S.A Long-Term Investments

The latest long-term investments for PROC is $6.2M as of September 2023. That compares with $2.4M in the prior-year period — up 154.9% year over year. Investors often review this figure alongside Procaps Group S.A's historical trend and sector peers before judging valuation or financial health.

Over the past year, PROC's long-term investments moved from $2.4M to $6.2M — a 154.9% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Procaps Group S.A's operating scale or balance-sheet position.

A long-term investments figure of $6.2M for PROC is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting PROC's long-term investments ($6.2M), review year-over-year change from $2.4M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Procaps Group S.A's long-term investments against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.